CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Maduck Sean See Remarks | Option exercise 10b5-1 | +20,000 | $8.27 | $165K | 27,904 |
| 2025-11-03 | Maduck Sean See Remarks | Sale 10b5-1 | −20,000 | $73.99 | $1.5M | 7,904 |
| 2025-11-03 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 261,986 | ||
| 2025-10-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $14.08 | $31K | 2,200 |
| 2025-10-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $87.54 | $193K | 0 |
| 2025-10-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 1,100 | ||
| 2025-10-07 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 25,287 |
| 2025-10-07 | Guyer William Chief Development Officer | Sale 10b5-1 | −20,000 | $89.94 | $1.8M | 5,287 |
| 2025-10-07 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 310,000 | ||
| 2025-10-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −5,616 | $84.29 | $473K | 2,815,754 |
| 2025-10-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −31,190 | $85.16 | $2.7M | 2,784,564 |
| 2025-10-01 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −3,194 | $85.67 | $274K | 2,781,370 |
| 2025-10-01 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $13.56 | $68K | 15,277 |
| 2025-10-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −927 | $83.71 | $78K | 14,350 |
| 2025-10-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −3,473 | $84.92 | $295K | 10,877 |
| 2025-10-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −600 | $85.39 | $51K | 10,277 |
| 2025-10-01 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 21,571 | ||
| 2025-10-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +1,986 | $5.05 | $10K | 9,890 |
| 2025-10-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +18,014 | $8.27 | $149K | 27,904 |
| 2025-10-01 | Maduck Sean See Remarks | Sale 10b5-1 | −959 | $83.73 | $80K | 26,945 |
Page 18 of 61 · 1,220 trades